Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty, Student
Program Director Dr. Evangelia Ieronymaki reflects on how an experiential learning opportunity immersed students in the planning, coordination, and construction challenges shaping the Second Avenue Subway Phase 2 project.
Faculty, Impacts and Insights, School
From the FIFA World Cup to cybersecurity and public infrastructure, project leaders discussed what it takes to anticipate challenges, manage risk, and keep complex initiatives on track.
Faculty
Diverse talents, humility, and shared mission show how teamwork can solve complex challenges better than individual brilliance.
All News
